Article info
PDFEthics
Research
Moving towards a better path? A mixed-method examination of China’s reforms to remedy medical corruption from pharmaceutical firms
- Correspondence to Dr Zhaoxin Wang; supercell002{at}sina.com and Professor Leiyu Shi; lshi2{at}jhu.edu
Citation
Moving towards a better path? A mixed-method examination of China’s reforms to remedy medical corruption from pharmaceutical firms
Publication history
- Received July 4, 2017
- Revised December 6, 2017
- Accepted December 8, 2017
- First published February 8, 2018.
Online issue publication
January 10, 2022
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/